Synbio Tech

Synbio Tech Equity

The The Equity of Synbio Tech (1295.TWO) as of Oct 18, 2026 is 1.33 B TWD. In the previous year, The Equity was 1.08 B TWD — a change of 23.23% (higher).

Equity

1.33 BTWD

YoY

23.23%

Last updated:

In 2025, Synbio Tech's equity was 1.33 B TWD, a 23.23% increase from the 1.08 B TWD equity in the previous year.

The Synbio Tech Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2020
758.45 M TWD
Jan 1, 2021
863.17 M TWD
Jan 1, 2022
897.68 M TWD
Jan 1, 2023
942.97 M TWD
Jan 1, 2024
1.08 B TWD
Jan 1, 2025
1.33 B TWD
The Synbio Tech Equity history
YEAREquityYoY
1.33 BTWD+23.23%
1.08 BTWD+14.47%
942.97 MTWD+5.04%
897.68 MTWD+4.00%
863.17 MTWD+13.81%
758.45 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Synbio Tech Stock analysis

What does Synbio Tech do? Synbio Tech Inc, headquartered in Kaohsiung, Taiwan, operates in the Health Care sector within the Biotechnology industry. The company, listed on 13 December 2023, specializes in the development and application of lactic acid bacteria. Its main products include lactic acid bacteria powder, starter culture, fermentation broth, and various beverages. These products are utilized in human health care, green livestock and aquaculture breeding, plant preservation, and the production of fermented foods and beverages, including functional health foods and pet food. Synbio Tech is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Synbio Tech's Equity

Synbio Tech's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Synbio Tech's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Synbio Tech's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Synbio Tech's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Synbio Tech’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Synbio Tech stock

The Equity of Synbio Tech is 1.33 B TWD in 2025.

The Equity of Synbio Tech changed from 1.08 B TWD to 1.33 B TWD, representing a 23.23% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Synbio Tech since 2006 – with annual values, charts, and detailed analysis.

The Equity's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Synbio Tech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Synbio Tech

All Key Metrics — Synbio Tech